Patent Ductus Arteriosus in the Premature Infant: A Clinical Dilemma

Newborn and Infant Nursing Reviews

Volumn 6, Issue 3, 2006, Pages 151-157

  Markham, Melinda ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Ductus Arteriosus; Infants; Left to Right shunting; PDA; Prematurity

Indexed keywords

EID: 33747769572     PISSN: 15273369     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.nainr.2006.05.004     Document Type: Article

References (36)

1. Wyllie J. Treatment of patent ductus arteriosus. Semin Neonatol 8 (2003) 425-432
2. Fraser C.D. Aortopulmonary septal defects and patent ductus arteriosus. In: Gay S.M., and Gery L. (Eds). Critical heart disease in infants and children (1995), Mosby, St. Louis (Mo) 716-723
3. Zahka K.G., and Patel C.R. The cardiovascular system. In: Fanaroff A.A., and Martin R.J. (Eds). Neonatal-perinatal medicine: diseases of the fetus and newborn. 7th ed. (2002), Mosby, St. Louis (Mo) 1138-1139
4. Rudolph A.M. Distribution and regulation of blood flow in the fetal and neonatal lamb. Circ Res 57 (1985) 811-821
5. Clyman R.I., Chan C.Y., Mauray F., et al. Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia, and gestation. Pediatr Res 45 (1999) 19-29
6. Gentile R., Stevenson G., Dooley T., et al. Pulsed Doppler echocardiographic determination of time of ductal closure in normal newborn infants. J Pediatr 98 (1981) 443-448
7. Shimada S., Kasai T., Hoshi A., et al. Cardiocirculatory effects of patent ductus arteriosus in extremely low-birth-weight infants with respiratory distress syndrome. Pediatr Int 45 (2003) 255-262
8. Evans N., Malcolm G., Osborn D., et al. Diagnosis of patent ductus arteriosus in preterm infants. NeoReviews 5 (2004) e86-e97
9. Holmstrom H., Hall C., and Thaulow E. Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 90 (2001) 184-191
10. Puddy V.F., Amirmansour C., Williams A.F., et al. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci (Lond) 103 (2002) 75-77
11. Sanjeev S., Pettersen M., Lua J., et al. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J Perinatol 25 (2005) 709-713
12. Bell E.F., and Acarregui M.J. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev (2001) CD000503
13. Lee J., Rajadurai V.S., Tan K.W., et al. Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants. Pediatrics 112 (2003) 345-350
14. Achanti B., Yeh T.F., and Pildes R.S. Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus. Clin Invest Med 9 (1986) 250-253
15. Cotton R.B., Haywood J.L., and Fitzgerald G.A. Symptomatic patent ductus arteriosus following prophylactic indomethacin: a clinic and biochemical appraisal. Biol Neonate 60 (1991) 273-282
16. Fowlie P.W. Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev (2002) CD000174
17. Young T.E., and Mangum B. Indomethacin. Neofax: a manual of drugs used in neonatal care. 18th ed. (2005), Acorn Publishing, Raleigh, NC 124-125
18. Gersony W.M., Peckham G.J., Ellison R.C., et al. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 102 (1983) 895-906
19. Sperandio M., Beedgen B., Feneberg R., et al. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation. Pediatrics 116 (2005) 1361-1366
20. Herrera C., Holberton J., and Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (2004) CD003480
21. Watterberg K.L., Gerdes J.S., Cole C.H., et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 114 (2004) 1649-1657
22. Cooke L., Steer P., and Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (2003) CD003745
23. Mosca F., Bray M., Lattanzio M., et al. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 131 (1997) 549-554
24. Pezzati M., Vangi V., Biagiotti R., et al. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 135 (1999) 733-738
25. Van Overmeire B., Vanhagendoren S., Schepens P.J., et al. The influence of ibuprofen-lysine on unbound bilirubin plasma levels in preterm neonates. Pediatr Res 55 (2004) 474A
26. Ohlsson A., Walia R., and Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev (2003) CD003481
27. Shah S.S., and Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev (2006) CD004213
28. Gournay V., Savagner C., Thiriez G., et al. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 359 (2002) 1486-1488
29. Aranda J.V., Varvarigou A., Beharry K., et al. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr 86 (1997) 289-293
30. Desfrere L., Zohar S., Morville P., et al. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharm Ther 30 (2005) 121-132
31. Heyman E., Morag I., Batash D., et al. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics 112 (2003) e354
32. Koehne P.S., Bein G., Alexi-Meskhishvili V., et al. Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. J Perinat Med 29 (2001) 327-334
33. Kimball T.R., Ralston M.A., Khoury P., et al. Effect of ligation of patent ductus arteriosus on left ventricular performance and its determinants in premature neonates. J Am Coll Cardiol 27 (1996) 193-197
34. Marshall D.D., Kotelchuck M., Young T.E., et al. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. Pediatrics 104 (1999) 1345-1350
35. Rojas M.A., Gonzalez A., Bancalari E., et al. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 126 (1995) 605-610
36. Schmidt B., Davis P., Moddemann D., et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 344 (2001) 1966-1972